News & Updates

Is ART-free remission feasible in children born with HIV who received ART very early in life?

13 Mar 2024 by

In the IMPAACT* P1115 study presented at CROI 2024, four children who received antiretroviral therapy (ART) for HIV very early in life remained free of detectable HIV for over a year after a break in their ART regimen.

Is ART-free remission feasible in children born with HIV who received ART very early in life?

13 Mar 2024

TRuE-AD3: Ruxolitinib cream effective in children with AD

11 Mar 2024 by

Ruxolitinib cream, a topically administered selective Janus kinase 1/2 inhibitor, appears to be effective for mild-to-moderate atopic dermatitis (AD) in children aged 2–11 years, according to the TRuE-AD3 trial presented at AAAAI 2024.

TRuE-AD3: Ruxolitinib cream effective in children with AD

11 Mar 2024

Illicit drug, substance use during pregnancy linked to risk of malignancies in offspring

10 Mar 2024

Pregnant moms who use tobacco, alcohol, marijuana, or cocaine may be putting their babies at risk of several types of cancer, including nonglioma central nervous system tumours and non-Hodgkin lymphoma, as shown in a study.

Illicit drug, substance use during pregnancy linked to risk of malignancies in offspring

10 Mar 2024

In utero exposure to COVID-19 vaccine does not harm early infant development

09 Mar 2024 by

Babies born to mothers who were vaccinated against COVID-19 during pregnancy are not at risk of developmental delays, according to a study.

In utero exposure to COVID-19 vaccine does not harm early infant development

09 Mar 2024

Physical activity boosts mental health in children with neurodevelopmental disorders

08 Mar 2024

Physical activity appears to be beneficial in children and adolescents with different types of neurodevelopmental disorders, with such interventions having positive effects on cognitive function, psychological well-being, internalizing, and externalizing problems, according to the results of a systematic review and meta-analysis.

Physical activity boosts mental health in children with neurodevelopmental disorders

08 Mar 2024

Sebetralstat fares well as oral therapy for HAE

08 Mar 2024 by

In the phase III KONFIDENT trial, oral sebetralstat provides rapid symptom relief, cuts treatment burden, and facilitates early treatment in individuals with hereditary angioedema (HAE) attacks.

Sebetralstat fares well as oral therapy for HAE

08 Mar 2024

Original New Drug Application Approvals by US FDA (16-29 February 2024)

06 Mar 2024

New drug applications approved by US FDA as of 16-29 February 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-29 February 2024)

06 Mar 2024

OUtMATCH: Omalizumab gains FDA nod for IgE-mediated food allergies

05 Mar 2024 by

Omalizumab scores in the NIH*-sponsored phase III OUtMATCH** trial, increasing the threshold for an allergic reaction to peanut and other common food allergens in children and adults with multiple food allergies.

OUtMATCH: Omalizumab gains FDA nod for IgE-mediated food allergies

05 Mar 2024

Omalizumab helps reduce allergic reactions to foods in kids

01 Mar 2024 by

In young children with multiple food allergies, a treatment course with omalizumab appears to increase tolerance to peanuts and other common food allergens.

Omalizumab helps reduce allergic reactions to foods in kids

01 Mar 2024

Major adverse kidney events common among young people undergoing CKRT

29 Feb 2024

Almost two-thirds of youths undergoing continuous kidney replacement therapy (CKRT) have major adverse kidney events 90 days after CKRT initiation (MAKE-90), with risk factors including cardiac comorbidity, time to CKRT initiation, and liberation patterns, according to a study.

Major adverse kidney events common among young people undergoing CKRT

29 Feb 2024

News & Updates

Filter by Specialty:

Specialty:

Is ART-free remission feasible in children born with HIV who received ART very early in life?

Is ART-free remission feasible in children born with HIV who received ART very early in life?

TRuE-AD3: Ruxolitinib cream effective in children with AD

TRuE-AD3: Ruxolitinib cream effective in children with AD

Illicit drug, substance use during pregnancy linked to risk of malignancies in offspring

Illicit drug, substance use during pregnancy linked to risk of malignancies in offspring

In utero exposure to COVID-19 vaccine does not harm early infant development

In utero exposure to COVID-19 vaccine does not harm early infant development

Physical activity boosts mental health in children with neurodevelopmental disorders

Physical activity boosts mental health in children with neurodevelopmental disorders

Sebetralstat fares well as oral therapy for HAE

Sebetralstat fares well as oral therapy for HAE

Original New Drug Application Approvals by US FDA (16-29 February 2024)

Original New Drug Application Approvals by US FDA (16-29 February 2024)

OUtMATCH: Omalizumab gains FDA nod for IgE-mediated food allergies

OUtMATCH: Omalizumab gains FDA nod for IgE-mediated food allergies

Omalizumab helps reduce allergic reactions to foods in kids

Omalizumab helps reduce allergic reactions to foods in kids

Major adverse kidney events common among young people undergoing CKRT

Major adverse kidney events common among young people undergoing CKRT